Maven Invests Growth Capital in Covestus; Covestus Acquires Probio7

Maven's MBO Fund II Backs Covestus to Acquire UltraDEX and Dentyl

December 9, 2025

Consumer Products

Maven’s MBO Fund II, together with other Maven client funds, has committed up to £15 million to back Covestus, a Cheltenham-based consumer healthcare platform, to accelerate its buy-and-build strategy. The initial investment will support Covestus’s acquisition of two oral-care brands, UltraDEX and Dentyl, from Venture Life Group plc to strengthen its UK and international oral-care footprint.

Maven VCTs Lead Investment in Quorum Cyber

July 21, 2020

Cybersecurity

The Maven VCTs have led a growth investment in Quorum Cyber alongside the Scottish Investment Bank. The funding will be used to scale the business — expanding sales and marketing, product innovation and accelerating geographic expansion for the Edinburgh-headquartered managed security services provider.

Maven Invests in Pagabo and Sypro

June 2, 2021

Government & Public Sector

The Maven UK Regional Buyout Fund has completed an investment in Pagabo, a UK procurement services specialist, and Sypro, a contract management and compliance software provider. The funding will support the Group’s next stage of growth — scaling the combined procurement and contract-management proposition to capitalise on increased public sector infrastructure spend.

Vision Healthcare Acquires AixSwiss (Nupure)

September 23, 2022

Consumer Products

Vision Healthcare has acquired 100% of AixSwiss BV, the Dutch owner of the fast-growing probiotic nutraceutical brand Nupure, which generated approximately €20m in sales in 2022. The deal strengthens Vision Healthcare’s pan‑European digital omni‑channel VMS and nutraceutical platform and adds probiotic product capability and DACH e‑commerce reach to its portfolio.

Maven VCTs Invest £2 Million in MirrorWeb

October 28, 2020

Cloud & SaaS

The Maven VCTs (managed by Maven Capital Partners) have invested up to £2.0 million in MirrorWeb, a Manchester-based cloud SaaS provider of web-archiving and digital compliance solutions. The growth capital will support MirrorWeb’s product development and expansion plans in the UK and United States; Maven originally invested in the business in 2018 via NPIF.

Gryphon-Backed Metagenics Acquires UK Probiotic Brand Symprove

January 23, 2026

Consumer Products

Gryphon Investors-backed Metagenics has acquired Symprove, a UK-based probiotic brand, from bd-capital. The deal — terms undisclosed — was completed alongside a strategic debt recapitalization to provide Metagenics with additional capital for organic investment and future M&A; Symprove will continue to be led by CEO Will Bowler.